Home » Topics » BioWorld Science

BioWorld Science
RSS

Ligand grants CRDC Asian rights to develop COVID-19 antiviral using BEPro technology

Oct. 22, 2021

Cedilla announces lead programs focused on conditional inhibition of TEAD and CDK2

Oct. 22, 2021

Purnovate selects PNV-5030 as lead compound in pain program

Oct. 22, 2021

SLFN11 predicts treatment response to TAS-1553 in AML

Oct. 22, 2021

Loxo Oncology details discovery and testing of PI3Kalpha and FGFR inhibitors

Oct. 22, 2021

GLI1 inhibition as a novel strategy for the treatment of uterine leiomyosarcoma

Oct. 22, 2021

Researchers identify new GPR52 agonists

Oct. 22, 2021

Enyo Pharma presents ICD inducers

Oct. 22, 2021

Takeda Pharmaceutical synthesizes new somatostatin SST4 receptor agonists

Oct. 22, 2021

Merck & Co. divulges new coagulation factor XIa inhibitors

Oct. 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...